Maxime Richer

1.2k total citations
26 papers, 651 citations indexed

About

Maxime Richer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Maxime Richer has authored 26 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Maxime Richer's work include Glioma Diagnosis and Treatment (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Ion channel regulation and function (3 papers). Maxime Richer is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Ion channel regulation and function (3 papers). Maxime Richer collaborates with scholars based in Canada, United States and Australia. Maxime Richer's co-authors include Phedias Diamandis, Anglin Dent, Randy Van Ommeren, Kevin Faust, Ugljesa Djuric, Aida M. Mamarbachi, Pierre Blier, René Hen, Denis J. Dupré and David Mathieu and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Neurology and Scientific Reports.

In The Last Decade

Maxime Richer

24 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxime Richer Canada 13 227 123 118 91 89 26 651
Chiara Di Resta Italy 19 495 2.2× 25 0.2× 156 1.3× 100 1.1× 49 0.6× 63 1.1k
Michael Tran Duong United States 12 228 1.0× 118 1.0× 18 0.2× 201 2.2× 67 0.8× 25 769
Shannon M. Standridge United States 17 145 0.6× 25 0.2× 27 0.2× 16 0.2× 47 0.5× 39 772
Bliss Chang United States 9 285 1.3× 40 0.3× 20 0.2× 61 0.7× 20 0.2× 17 737
Raffaella Cascella Italy 18 417 1.8× 10 0.1× 78 0.7× 114 1.3× 12 0.1× 67 1000
Andrea Termine Italy 11 149 0.7× 21 0.2× 39 0.3× 25 0.3× 41 0.5× 35 546
Zuojun Geng China 12 112 0.5× 13 0.1× 24 0.2× 81 0.9× 10 0.1× 31 797
Allison S. Dobry United States 14 247 1.1× 24 0.2× 786 6.7× 38 0.4× 7 0.1× 31 1.3k
Carlo Fabrizio Italy 10 110 0.5× 21 0.2× 35 0.3× 22 0.2× 41 0.5× 29 373

Countries citing papers authored by Maxime Richer

Since Specialization
Citations

This map shows the geographic impact of Maxime Richer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Richer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Richer more than expected).

Fields of papers citing papers by Maxime Richer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Richer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Richer. The network helps show where Maxime Richer may publish in the future.

Co-authorship network of co-authors of Maxime Richer

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Richer. A scholar is included among the top collaborators of Maxime Richer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Richer. Maxime Richer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saïkali, Stéphan, Peter V. Gould, Maxime Richer, et al.. (2025). Adult Neurogenesis in the Subventricular Zone of Patients with Huntington's and Parkinson's Diseases and following Long‐Term Treatment with Deep Brain Stimulation. Annals of Neurology. 97(5). 894–906. 2 indexed citations
2.
Levy, Zohar, et al.. (2025). A18 EXPLORING TRAINED IMMUNITY IN INTESTINAL EPITHELIAL CELLS DURING TYPE 2 IMMUNE RESPONSES. Journal of the Canadian Association of Gastroenterology. 8(Supplement_1). i8–i8.
3.
Robitaille, Karine, Myreille D’Astous, Alain Bergeron, et al.. (2025). A versatile and efficient method to isolate nuclei from low-input cryopreserved tissues for single-nuclei transcriptomics. Scientific Reports. 15(1). 5581–5581. 1 indexed citations
4.
Avery, Lisa, Dorsa Sohaei, Maxime Richer, et al.. (2023). Discovery of novel glioma serum biomarkers by proximity extension assay. Clinical Proteomics. 20(1). 12–12. 11 indexed citations
6.
Zvaritch, Elena, et al.. (2019). Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: a case series. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 66(5). 540–545. 16 indexed citations
7.
Lebel, Réjean, et al.. (2019). Automated detection and quantification of breast cancer brain metastases in an animal model using democratized machine learning tools. Scientific Reports. 9(1). 17333–17333. 17 indexed citations
8.
Dent, Anglin, Kevin Faust, Maxime Richer, et al.. (2019). Physician perspectives on integration of artificial intelligence into diagnostic pathology. npj Digital Medicine. 2(1). 28–28. 185 indexed citations
9.
Shi, Minghan, Malathi Anantha, Mohamed Wehbe, et al.. (2018). Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats. Journal of Nanobiotechnology. 16(1). 77–77. 43 indexed citations
10.
Richer, Maxime, et al.. (2018). The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis. Clinical Rheumatology. 37(8). 2297–2302. 14 indexed citations
11.
Iorio‐Morin, Christian, et al.. (2016). Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial. Trials. 17(1). 235–235. 50 indexed citations
12.
Bissel, Stephanie J., Roland N. Auer, Jason Chiang, et al.. (2015). Human Parechovirus 3 Meningitis and Fatal Leukoencephalopathy. Journal of Neuropathology & Experimental Neurology. 74(8). 767–777. 39 indexed citations
13.
Richer, Maxime, et al.. (2013). Vaginal Epithelioid Angiosarcoma. Journal of Lower Genital Tract Disease. 18(2). E38–E42. 4 indexed citations
14.
Richer, Maxime, Louis Villeneuve, Phan Trieu, et al.. (2008). GABA-B1 Receptors are Coupled to the ERK1/2 MAP Kinase Pathway in the Absence of GABA-B2 Subunits. Journal of Molecular Neuroscience. 38(1). 67–79. 11 indexed citations
15.
Dupré, Denis J., et al.. (2007). Dopamine Receptor-interacting Protein 78 Acts as a Molecular Chaperone for Gγ Subunits before Assembly with Gβ. Journal of Biological Chemistry. 282(18). 13703–13715. 56 indexed citations
16.
Richer, Maxime, et al.. (2006). Interactions between GABA-B1 receptors and Kir 3 inwardly rectifying potassium channels. Cellular Signalling. 18(12). 2172–2181. 54 indexed citations
17.
Richer, Maxime, René Hen, & Pierre Blier. (2002). Modification of serotonin neuron properties in mice lacking 5-HT1A receptors. European Journal of Pharmacology. 435(2-3). 195–203. 56 indexed citations
18.
Richer, Maxime, Hen R, & Pierre Blier. (2000). Assessment of the function of presynaptic 5-HT and norepinephrine receptors in 5-HT1A knockout mice. The Society for Neuroscience Abstracts. 26. 4711. 3 indexed citations
19.
Gaudreau, Pierrette, et al.. (1992). Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I. Journal of Medicinal Chemistry. 35(2). 346–350. 15 indexed citations
20.
Lamarche, Nathalie, B. Massie, Maxime Richer, Hélène Paradis, & Yves Langelier. (1990). High Level Expression in 293 Cells of the Herpes Simplex Virus Type 2 Ribonucleotide Reductase Subunit 2 Using an Adenovirus Vector. Journal of General Virology. 71(8). 1785–1792. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026